Transcatheter mitral valve interventions
The past decade has been a revolution in the use of percutaneous procedures for mitral valve (MV) therapy, and currently there are several devices in different stages of development. The enhanced imaging with 3D transoesophageal echocardiography (TEE), as well as computed tomography (CT) and fusion imaging, has led to better understanding of MV anatomy, which in turn helped promote the development of new devices, as well as being crucial for procedural guidance and effective valve repair or replacement. In addition to the new devices, fusion imaging promises to result in even better outcomes in the future by enhancing device deployment. While initially device development for the MV focused on degenerative mitral regurgitation (MR), more recent studies have demonstrated that reducing the severity of secondary MR with transcatheter techniques may provide symptomatic benefit with regards to cardiac heart failure and improved survival. Percutaneous therapies for the MV, as they are less invasive, have many advantages that may supplant surgical techniques, provided that they reduce morbidity and mortality and have comparable efficacy. In this chapter we review transcatheter MV interventions for mitral stenosis (MS) and MR.